tiprankstipranks

Jiangsu Recbio Schedules Board Meeting to Review Annual Results

Story Highlights
Jiangsu Recbio Schedules Board Meeting to Review Annual Results

Don’t Miss TipRanks’ Half-Year Sale

Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has shared an announcement.

Jiangsu Recbio Technology Co., Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the potential payment of a final dividend, which could impact the company’s financial distribution to its stakeholders.

More about Jiangsu Recbio Technology Co., Ltd. Class H

Jiangsu Recbio Technology Co., Ltd. is a joint stock company based in the People’s Republic of China, operating within the biotechnology industry. The company focuses on developing and providing innovative biotechnological solutions and products.

YTD Price Performance: -17.05%

Average Trading Volume: 93,969

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: HK$3.72B

See more insights into 2179 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1